Journal of the National Comprehensive Cancer Network

Title Publication Date Language Citations
Your Words Mean Something!2023/02/01
Thank You to 2022 JNCCN Reviewers2023/02/01
Highlights of the NCCN Oncology Research Program2023/02/01
Small Cell Lung Cancer in Light/Never Smokers – A Role for Molecular Testing?2023/04/01
Erratum2023/02/01
Impact of Asian Race on Prognosis in De Novo Metastatic Prostate Cancer2023/07/01
A Glimpse Into the Future2023/07/01
NCCN News2023/07/01
Determining PARP Inhibition as a Treatment Strategy in Melanoma Based on Homologous Recombination Deficiency–Related Loss of Heterozygosity2023/07/01
Cardiovascular Implications of Vascular Endothelial Growth Factor Inhibition Among Adolescents/Young Adults in ECOG-ACRIN E28052023/07/01
Erratum2023/07/01
Social Determinants of Health and Cardiac Risk for Patients With Breast Cancer: Beyond Racial Disparities2023/07/01
Highlights of the NCCN Oncology Research Program2023/07/01
Barriers and Facilitators Impacting Lung Cancer Screening Uptake Among Black Veterans: A Qualitative Study2024/04/18
Cost-Effectiveness of Unselected Multigene Germline and Somatic Genetic Testing for Epithelial Ovarian Cancer2024/04/18
Loneliness and Mortality Risk Among Cancer Survivors in the United States: A Retrospective, Longitudinal Study2024/04/25
Racial Differences in Germline Genetic Testing Completion Among Males With Pancreatic, Breast, or Metastatic Prostate Cancers2024/04/17
Breakthrough Therapy Cancer Drugs and Indications With FDA Approval: Development Time, Innovation, Trials, Clinical Benefit, Epidemiology, and Price2024/04/22
Revisiting the Association of ECOG Performance Status With Clinical Outcomes in Diverse Patients With Cancer2024/04/23
Life Years Gained From the FDA Accelerated Approval Program in Oncology: A Portfolio Model2024/04/22
Health Care Lobbying and Oncology2024/04/19
Clinical Risks for Chronic Lymphocytic Leukemia2024/04/01
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.20242024/04/01
The Pancreatic Cancer Early Detection (PRECEDE) Study is a Global Effort to Drive Early Detection: Baseline Imaging Findings in High-Risk Individuals2024/04/01
Aligning With the National Cancer Plan2024/04/01
Highlights of the NCCN Oncology Research Program2024/04/01
NCCN News2024/04/01
Prostate Cancer, Version 3.20242024/04/01
Hormone Receptor–Positive Breast Cancer Sensitive to Pembrolizumab: Evidence of the Pathogenicity of the MLH1 Variant 1835del32023/11/01
BRAF/MEK Inhibition as a Bridge to Immunotherapy for Symptomatic BRAF V600 Melanoma Brain Metastases: A Case Series2023/10/01